Chemoinformaics analysis of CYANIDIN-3-O-RHAMNOSIDE
| Molecular Weight | 433.389 | nRot | 3 |
| Heavy Atom Molecular Weight | 412.221 | nRig | 23 |
| Exact Molecular Weight | 433.113 | nRing | 4 |
| Solubility: LogS | -3.806 | nHRing | 2 |
| Solubility: LogP | 1.379 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 52 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 2 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 21 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 10 | No. of Arom Bond | 17 |
| nHA | 9 | APOL | 57.0927 |
| nHD | 7 | BPOL | 26.2753 |
| QED | 0.237 |
| Synth | 4.261 |
| Natural Product Likeliness | 2.119 |
| NR-PPAR-gamma | 0.948 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.82 |
| HIA | 0.583 |
| CACO-2 | -6.244 |
| MDCK | 0.00000531 |
| BBB | 0.024 |
| PPB | 0.914829 |
| VDSS | 0.774 |
| FU | 0.111895 |
| CYP1A2-inh | 0.13 |
| CYP1A2-sub | 0.072 |
| CYP2c19-inh | 0.017 |
| CYP2c19-sub | 0.056 |
| CYP2c9-inh | 0.004 |
| CYP2c9-sub | 0.294 |
| CYP2d6-inh | 0.066 |
| CYP2d6-sub | 0.218 |
| CYP3a4-inh | 0.015 |
| CYP3a4-sub | 0.023 |
| CL | 11.482 |
| T12 | 0.834 |
| hERG | 0.007 |
| Ames | 0.785 |
| ROA | 0.099 |
| SkinSen | 0.204 |
| Carcinogencity | 0.219 |
| EI | 0.247 |
| Respiratory | 0.06 |
| NR-Aromatase | 0.94 |
| Antiviral | Yes |
| Prediction | 0.852528 |